Follow this innovation
[ via 
] [?]
Bilins as anticancer agents
Harvard University Office of Technology Development
posted on 07/09/2010
MARKETS ADDRESSED:
Therapeutic small molecules
INNOVATIONS & ADVANTAGES:
A remarkable discovery at Harvard Medical School has led to the recognition that a naturally-occurring small molecule and analogs thereof possess potent anticancer properties through their ability to control cell differentiation. According to the invention, bilins are administered to induce terminal differentiation of dividing mammalian cells and thereby halt uncontrolled cell proliferation. This invention represents a major conceptual departure from traditional, signaling pathway-targeted strategies for tissue engineering and for the treatment of both benign and malignant cell proliferative disorders.
File Number: 1603
Other Information:
Investigator(s)
Kenneth H. Falchuk
Contact
Michal Preminger, (617) 432-0920
This innovation currently is not available for online licensing. Please contact Michal Preminger at Harvard University Office of Technology Development for more information.
request more info
ProfileFind more innovations
